Fig. 3From: Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment processRecent case studies show the difference in how HAS and IQWiG handle HRQoL evidence in dossiers submitted to them. Case studies, selected by our ex-HTA directors, show, for HAS [24,25,26,27,28,29,30,31], NICE [32,33,34,35] and IQWiG [36,37,38,39,40,41,42,43], whether the HRQoL data submitted was considered or not, and the rationale for the discrepancies. Note: NICE did not review all the products that HAS and IQWiG reviewed, this is indicated by “n/a”Back to article page